A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like； ring B is arylene optionally having substituent(s) and the like； m=0-2； n=1-5； X is a bond and the like； Y is a bond and the like； and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.
